That study was led by Dr Hahn, who was originally skeptical about the DurAVR's benefit but was literally giddy with excitement talking about the valve in the recent TCT panel video.
- Forums
- ASX - By Stock
- AVR
- Ann: 30-day Haemodynamic Results from the DurAVR US EFS Trial
Ann: 30-day Haemodynamic Results from the DurAVR US EFS Trial, page-43
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
|
|||||
Last
$19.95 |
Change
0.200(1.01%) |
Mkt cap ! $383.4M |
Open | High | Low | Value | Volume |
$19.95 | $20.00 | $19.83 | $183.2K | 9.187K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 25 | $19.75 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.95 | 472 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 25 | 19.750 |
1 | 15 | 19.670 |
1 | 500 | 19.020 |
1 | 500 | 19.010 |
2 | 502 | 19.000 |
Price($) | Vol. | No. |
---|---|---|
20.000 | 1348 | 2 |
20.100 | 100 | 1 |
20.120 | 420 | 1 |
20.400 | 678 | 1 |
20.500 | 4930 | 2 |
Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
AVR (ASX) Chart |